Standardization for transcriptomic molecular markers to screen human colon cancer

Area of Science:

• Molecular diagnostics
• Oncology
• Biomarker discovery

Background:

• Colon cancer incidence is rising globally.
• Accurate and reliable diagnostic markers are needed.
• Transcriptomic approaches show promise for early detection.

Purpose of the Study:

• To establish standardized performance criteria for a transcriptomic colon cancer marker approach.
• To ensure consistent and reproducible test results across different laboratories.
• To guide future clinical studies for validating this screening method.

Main Methods:

• Recommending specific conditions for stool sample preservation and shipping (e.g., preservative, cold packs at 4°C).
• Demonstrating that colonocyte isolation is not necessary for adequate RNA extraction.
• Utilizing a commercial total RNA extraction kit (Qiagen) with RLT buffer to remove bacterial RNA and yield high-quality human RNA.
• Selecting genes from the NCI's Cancer Genome Anatomy Project and using PCR primers spanning multiple exons.
• Employing semiquantitative PCR with multiple reference housekeeping genes for enhanced quantitative accuracy.

Main Results:

• Standardized methods ensure consistent test performance in any laboratory setting.
• Specific protocols for sample preservation and RNA extraction yield high-quality, undegraded human RNA.
• The chosen transcriptomic markers and PCR methods provide good results for colon cancer detection.

Conclusions:

• Standardized testing conditions are essential for the reliable clinical application of transcriptomic colon cancer markers.
• Further large-scale prospective randomized clinical studies are imperative to determine the sensitivity and specificity of this approach.
• This transcriptomic screening method holds potential for early detection of colon cancer, addressing its increasing global incidence.